πŸ‡ΊπŸ‡Έ FDA
Patent

US 11696904

Prodrug for therapeutic applications

granted A61KA61K31/137A61K31/225

Quick answer

US patent 11696904 (Prodrug for therapeutic applications) held by The Regents of the University of California expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/137, A61K31/225, A61K31/277, A61K31/397